Matica Biotechnology, Inc.

🔬 Outsourcing in Cell & Gene Therapy Hits New Highs — and It's About More Than Just Capacity According to BioPlan Associates, 82.6% of CGT companies now outsource key functions — a massive leap over the past decade. Today, it’s not just about production; CGT developers are relying on CDMOs for analytical testing, strategic flexibility, and regulatory guidance in an increasingly complex global landscape. At Matica Bio, we understand these evolving demands. Our team is built to deliver regulatory-aligned analytical testing, agile capacity solutions, and purpose-built services designed to accelerate CGT programs from clinical development through commercialization. From specialized analytics to GMP production, we partner with CGT innovators to deliver confidence and compliance at every step. 📖 Read more about the outsourcing trends and how they’re shaping the future of CGT: https://lnkd.in/gEkqn4hq ✏️ Contact Us: www.maticabio.com #MaticaBio #celltherapy #genetherapy #CGT #AnalyticalServices #Biomanufacturing #LifeSciences

There’s never been a better time to join Matica Bio. We are thriving – and hiring. Let’s grow together.   As the biotech landscape continues to evolve, we’re proud to be part of its forward momentum. At Matica Bio, we are forging new partnerships and our increasing number of CGT projects have opened the door for us to expand our team.   We are a purpose-driven CDMO that’s making real progress in advanced therapy manufacturing — and creating space for people who want to make a difference. This is a chance to join us at a pivotal moment in our journey. We’re looking for professionals who value collaboration, innovation, and meaningful work.   Here, you’ll find: 🔬 Purpose-driven work in viral vector manufacturing 🤝 A culture that values integrity, inclusion, and collaboration 🚀 A team moving forward with focus and intention   Interested? 🔗 https://lnkd.in/eTMb9ypZ 📧 jobs@maticabio.com   Whether you're exploring your options or looking for your next mission, we invite you to learn more. Let’s make an impact — together.

Matica Bio is excited to share that we’ll be participating in an upcoming Waters-hosted webinar on July 17th titled “Go Big with Wide Pore SEC: Methods for Profiling LNPs, Lentivirus, and DNA Constructs.” Our very own Kevin McManus, Analytical Development Scientist III from Matica Bio, will be sharing insights and expertise on AD in the Cell and Gene Therapy (CGT) field. Register today and don't miss this opportunity to learn new SEC methods for characterizing complex biomolecules like LNPs, Lentivirus, and plasmid DNA, and explore how novel wide pore technology supports robust, high-throughput performance from early discovery to late-stage development. 📅 Date: Thursday July 17, 11am ET 🧪 Topic: Wide Pore SEC for LNPs, Lentivirus, and DNA 🎙️ Register Here : https://lnkd.in/gQFpmC5n #MaticaBio #Genetherapy #AnalyticalDevelopment

🌟 Happy 4th of July! Let's celebrate innovation, independence, and the spirit of discovery that drives progress—from the lab to life. Wishing everyone a safe and joyful Independence Day. #FourthOfJuly #IndependenceDay

🌎 Join us at BIO International Convention 2025! We’re excited to connect with the Cell & Gene Therapy (CGT) community at #BIO2025! Our team is looking forward to meeting CGT innovators, sharing our insights on our cutting-edge manufacturing technologies, and exploring how we can support access to funding opportunities that help bring therapies to patients faster. Let’s shape the future of biotech—together. ⏲️ When : June 16–19 📍 Where : Boston Convention & Exhibition Center 📅 Schedule a Meeting : https://lnkd.in/gXxieSMg #BIO2025 #CGT #genetherapy #celltherapy #viralvector

🚀 Webinar Announcement We’re thrilled to partner with Bio-Rad for an upcoming live co-webinar: “Evaluation of BioRad's Vericheck ddPCR Empty Full Kit: Revolutionizing AAV8 Characterization for Gene Therapy” 🗓 Date: June 4, 2025 🕛 Time: 12:00 PM CST ✏️ Register Here: https://lnkd.in/gZrGsuWj Accurate characterization of AAV vectors is critical for the safety and efficacy of gene therapy products. In this session, we’ll explore how the Vericheck ddPCR Empty Full Kit enables a robust, precise, and scalable method for determining the %Empty to Full ratio of AAV8 capsids — a key quality attribute for AAV-based therapeutics. #genetherapy #celltherapy #analyticaldevelopment #assays #QC

📢 Partnership Announcement 📢 Matica Biotechnology and Texas A&M's NCTM are joining forces to provide end-to-end support for cell and gene therapy innovators — from early R&D to commercialization. By combining academic excellence with industrial execution, this collaboration streamlines development, reduces costs, and accelerates time-to-market for CGT products. Read the article : https://lnkd.in/gT6fsTPN #CGT #Biotech #Innovation #MaticaBio #NCTM #TexasAandM #Partnership

🌟 Meet Us at ASGCT – Booth #1737! We’re serving up more than just great coffee at our Barista Bar — let’s chat about your CGT needs and explore how we can support your next breakthrough. Our scientists will be on-site, ready to discuss real solutions for your project. ☕ Stop by, grab a cup, and let’s connect. See you soon! #ASGCT #genetherapy #celltherapy #viralvectors #coffee

[Introducing the MATICA Xcelerator Program] The MATICA Xcelerator Program is designed to provide early-stage CGT developers with more access to funding, strategic support, and access to top-tier expertise to help accelerate their therapies from discovery to clinical success. 🙋♂️Who Can Apply? Startups, biotech and foundations with CGT pipelines 🏆Awards - Sponsored development and manufacturing support - Direct investment or funding ✏️How to Apply If you’re ready to take your innovation to the next level, submit your application here: https://lnkd.in/gVcM7aZN Apply today to turn your transformative ideas into life-saving therapies. #genetherapies #celltherapies #viralvectors #accesstofund

🌟Join Us for Happy Hour at CYTO|PHL! We’re excited to invite you to a special Happy Hour at the CYTO|PHL facility on Wednesday, April 16! It’s the perfect opportunity to connect with our lead BD Christina McKenna, who will be sharing an innovative approach to the cell and gene therapy drug development cycle, introducing access to funding opportunities, and much more! 🌟 Come for the insights, stay for the networking and great conversation. We can’t wait to see you there! 📅 Date: Wednesday, April 16 📍 Location: CYTO|PHL Facility 🔗 RSVP/More Info: https://lnkd.in/g9hBQ8DV Co-sponsored by : Matica Bio & Drexel University #HappyHour #CellAndGeneTherapy #Networking